Article Details

Athira Pharma's stock falls 39% after placing its CEO on leave

Retrieved on: 2021-06-18 23:26:15

Tags for this article:

Click the tags to see associated articles and topics

Athira Pharma's stock falls 39% after placing its CEO on leave. View article details on hiswai:

Excerpt

based clinical-stage biopharma Athira Pharma (NSDQ:ATHA) is in a tailspin after the company's board put Leen Kawas, the firm's CEO, on temporary ...

Article found on: www.massdevice.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up